Ryan Selhorn's most recent trade in Aytu BioPharma Inc was a trade of 105 Common Shares done . Disclosure was reported to the exchange on Feb. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aytu BioPharma Inc | Ryan Selhorn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 105 | 16,000 (0%) | 0% | - | Common Shares | |
| Aytu BioPharma Inc | Ryan Selhorn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 105 | 0 | - | - | Restricted Stock Units | |
| Aytu BioPharma Inc | Ryan Selhorn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 14,000 | 15,895 (0%) | 0% | 0 | Common Shares |